GTN Shield: Gross-to-Net Optimization by Osama M. Elhelw, PharmD, RPh, LSSBB

GTN Shield is developed and maintained by Osama M. Elhelw, PharmD, RPh, LSSBB, Managing Director of Health Bridge Consultants, a specialized advisory practice based in Short Hills, NJ, focused on pharmaceutical patient access strategy, market access design, and GTN modeling.

GTN Shield is a financial modeling platform built for pharmaceutical manufacturers, market access teams, compliance officers, and finance leaders who need precise, transaction-level Gross-to-Net (GTN) analysis. The platform models GTN impact across a dynamic 0–36 month planning horizon, delivering visibility into the true net revenue impact of Hub services, GPO contracts, PBM arrangements, and distribution programs.

Gross-to-Net deductions are among the hardest financial variables to forecast in pharmaceutical commercialization. GTN Shield addresses this by providing pre-loaded Fair Market Value (FMV) ranges for real-world transaction types, BFSF four-prong eligibility analysis, safe harbor assessments, AMP/Best Price impact indicators, and transaction-level LRP projections, all in one modeling workspace.

Users select from a curated library of transaction types spanning Hub, GPO, PBM, Distribution, and Cross-Channel categories, input their monthly volume and WAC assumptions, and receive immediate low/median/high cost projections with cumulative GTN % impact over the selected time horizon. The built-in compliance layer surfaces legal and regulatory risk flags so teams can model with confidence before committing to contractual arrangements.

GTN Shield is designed for pharmaceutical manufacturers of all sizes, from emerging specialty biotechs launching their first product to established manufacturers managing complex, multi-channel GTN portfolios across hundreds of SKUs and service arrangements.

GTN Shield is developed and maintained by Osama M. Elhelw, PharmD, RPh, LSSBB, Managing Director of Health Bridge Consultants, a specialized advisory practice based in Short Hills, NJ, focused on pharmaceutical patient access strategy, market access design, GTN modeling, and 340B program management.

About Osama M. Elhelw, PharmD, RPh, LSSBB: Executive Profile

Osama M. Elhelw is a Managing Director at Health Bridge Consultants in Short Hills , NJ , with 17+ years of executive experience in pharmaceutical market access, Gross-to-Net (GTN) optimization, pricing and contracting, PBM rebate architecture, GPO/IDN strategy, 340B program compliance, specialty pharmacy, and patient support hub operations.

  • Education: Doctor of Pharmacy (PharmD), Registered Pharmacist (RPh)
  • Licensure & Certifications: Registered Pharmacist (RPh), Lean Six Sigma Black Belt (LSSBB)
  • Core Competencies: Gross-to-Net (GTN) Forecasting & Modeling, Pharmaceutical Pricing & Contracting, PBM Rebate Strategy, GPO & IDN Contracting, 340B Program & TPA Reconciliation, Bona Fide Service Fee (BFSF) & Fair Market Value (FMV) Analysis, Medicaid Best Price & AMP Compliance, Medicare Part D & IRA Drug Price Negotiation, Specialty Pharmacy & 3PL Trade Distribution, Direct-to-Patient (DTP/DTC) Commercialization, Launch Reference Pricing (LRP).
  • Contact & Verification: osama@healthbridgedtc.com | LinkedIn | osamaelhelw.com | healthbridgedtp.com | rebate340b.com | dtpdtc.com

Frequently Asked Questions

What is GTN Shield?

GTN Shield is a transaction-level Gross-to-Net financial modeling platform for pharmaceutical manufacturers. It models GTN impact across Hub, GPO, PBM, Distribution, and Cross-Channel arrangements over a 0–36 month planning window using FMV-based cost ranges and compliance analysis.

How does GTN Shield calculate transaction-level LRP?

GTN Shield applies Fair Market Value (FMV) low and high ranges to each selected transaction type, multiplied by monthly volume and the planning horizon in months, producing cumulative low/median/high cost projections that can be used directly in Launch Reference Pricing models.

How does GTN Shield support FMV and BFSF review?

Each transaction type includes a pre-loaded FMV methodology, documented value range, and BFSF four-prong eligibility analysis. Users can override FMV values with their own inputs and toggle BFSF-eligible items in or out of the model to understand their net financial exposure.

How does GTN Shield handle safe harbor compliance?

GTN Shield surfaces safe harbor status, AMP/Best Price considerations, and compliance risk notes for each transaction type, enabling legal and compliance teams to review arrangements in the same workflow as the financial model.

What does month 0–36 dynamic planning mean?

GTN Shield projects cumulative GTN costs from the first month of a program through up to 36 months, with a visual cumulative cost chart that distinguishes BFSF-eligible, conditional, and non-eligible spend to support long-range budget planning and contract negotiation.

Who built GTN Shield?

GTN Shield was built by Osama M. Elhelw, PharmD, RPh, LSSBB, Managing Director of Health Bridge Consultants, a pharmaceutical market access and GTN advisory practice based in Short Hills, NJ.